Biodegradable Polymer Mesh for Implantable Device Infection Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices, such as pacemakers and neurostimulators, face significant challenges with post-operative infections due to bacterial colonization and biofilm formation, which are resistant to antibiotics and lead to costly and risky surgical interventions.
Innovation Solution
Development of biodegradable polymer-coated surgical meshes that form pouches around implantable devices, incorporating antimicrobial agents like rifampin and minocycline to prevent bacterial colonization and biofilm formation, while also providing temporary stiffness to stabilize the device and reduce scar tissue formation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antimicrobial agents are incorporated into polymer-coated meshes, then bacterial colonization and biofilm formation are prevented, but device complexity increases
Solution Approach 1:
The patent applies composite materials by combining biodegradable polymers (such as polyglycolic acid, polylactic acid, or their copolymers) with antimicrobial agents (such as rifampin, minocycline, or other antibiotics) to create a coated mesh structure. This composite approach allows the polymer coating to serve dual functions: providing mechanical stability during healing and delivering antimicrobial therapy to prevent bacterial colonization and biofilm formation on the implantable device.
Solution Approach 2:
The biodegradable polymer coating acts as an intermediary carrier that facilitates the delivery of antimicrobial agents from the mesh structure to the surrounding tissue and bacteria. The polymer matrix controls the release kinetics of the antimicrobial drugs, ensuring sustained concentration at the infection risk site without requiring direct contact between the device surface and high doses of antimicrobial agents, thus preventing bacterial adhesion and biofilm formation effectively.
2Stability of the object's composition
If polymer coating is applied to provide temporary stiffness, then device stabilization is improved, but scar tissue formation may increase
Solution Approach 1:
The patent utilizes parameter changes by selecting biodegradable polymers with specific degradation characteristics and mechanical properties. The polymer coating is designed to provide temporary stiffness enhancement during the critical early healing phase (weeks 1-12), then gradually degrades and is absorbed by the body. This time-dependent parameter change allows the coating to stabilize the device when needed while eliminating the source of potential scar tissue formation (foreign material) after it has served its stabilizing function.
Solution Approach 2:
The biodegradable polymer coating functions as a temporary, self-resolving stabilizing element that is intentionally designed to be short-lived in the body. After providing the necessary mechanical stabilization during the healing period, the polymer naturally degrades and is metabolized, eliminating the need for permanent foreign material that could cause chronic scar tissue formation or capsule contracture. This approach trades long-term stability from a permanent coating for short-term stability from a biodegradable coating.
3Reliability
If antimicrobial agents are delivered through polymer coating, then infection prevention is enhanced, but manufacturing precision requirements increase
Solution Approach 1:
The patent addresses manufacturing precision challenges by controlling the physical and chemical parameters of the polymer coating formulation and application process. By adjusting polymer molecular weight, coating concentration, drying conditions, and crosslinking parameters, the coating thickness and antimicrobial agent distribution can be standardized to achieve uniform coverage. This parameter control ensures consistent antimicrobial release profiles across different batches while maintaining manufacturing feasibility.
Solution Approach 2:
The patent replaces complex mechanical coating application systems with chemical or physical methods of antimicrobial agent incorporation. Instead of requiring precise mechanical control during coating application, the antimicrobial agents are incorporated into the polymer matrix through chemical bonding, physical entrapment, or diffusion-based loading. This substitution reduces the stringency of manufacturing precision requirements while ensuring uniform distribution of the antimicrobial agents throughout the coating structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polymer-coated meshes effectively prevent bacterial colonization and biofilm formation, reducing the incidence of device-related infections, minimizing surgical complications, and providing prolonged drug release for pain management and infection prevention.
Implementation Method 1
the coating elutes one or more antimicrobial agents into surrounding tissue in amounts effective to prevent or retard the formation of biofilms on the device
Implementation Method 2
the coating provides temporary stiffness to the mesh so to stabilize the implantable device
Implementation Method 3
Prosthetic implants such as meshes, combination mesh products or other porous prostheses are commonly used to provide a physical barrier between types of tissue
Data Source
AI summary
Biodegradable polymer-coated surgical meshes formed into pouches are described for use with cardiac rhythm management devices (CRMs) and other implantable medical devices. Such meshes are formed into a receptacle, e.g., a pouch or other covering, capable of encasing, surrounding and/or holding the cardiac rhythm management device or other implantable medical device and preventing or retarding the formation of a biofilm.